News and events

Spotlight news

March 16, 2026

Our 2024/2025 ESG report marks a year of progress

We are pleased to announce the release of our ESG report for 2024/2025, which describes our collective progress across environmental sustainability, social responsibility and ethical governance.

All
  • All
  • News
  • Articles
  • Events

Privilege walk for rare diseases

Privilege (/ˈprɪvəlɪdʒ/) ‘A special right, advantage or immunity granted or available only to a particular person or group.’ We all know what privilege is, but it can be difficult to appreciate fully how privilege – or the lack thereof – can affect us. It is especially difficult to understand the challenges faced by people with…

Continue reading

PharmaTimes highlights Oxford PharmaGenesis rare disease insights

Oxford PharmaGenesis expertise in rare diseases was showcased in the April edition of PharmaTimes. The article ‘Time To Think Rare’ quoted Commercial Director Dr Richard White (http://tinyurl.com/hhk3xme) alongside other well-known figures in the rare diseases arena, including Alastair Kent (Director of the Genetic Alliance and Chair of Rare Disease UK) and Kay Parkinson (Chief Executive…

Continue reading

Oxford PharmaGenesis educates the next generation of value demonstration communicators at the 2nd Annual HEOR Writing Workshop

Oxford PharmaGenesis employees past and present were at the centre of the 2nd Annual HEOR Writing Workshop, held in Philadelphia on 17‑18 March 2016 and run by HealthEconomics.com and the Global Outcomes Group with sponsorship from the Mayes College of Healthcare Business and Policy. Attended by a mix of industry, agency and freelance medical writers,…

Continue reading

Westminster Health Forum Keynote Seminar indicates the need for an integrated HealthScience approach to healthcare policy, decision-making and communications

Dr Richard White, Commercial Director, and Dr Polly Field, Value Demonstration Leader, attended the Westminster Health Forum Keynote Seminar on Next steps for NICE, priorities for the pharmaceutical industry, and Accelerated Access Review. This was held on Thursday 14 January 2016 and Richard contributed the following article to the transcript of proceedings. The agenda for…

Continue reading

Oxford PharmaGenesis joins top companies to launch new corporate responsibility initiative

As a leading healthcare communications company, Oxford PharmaGenesis takes its corporate social responsibilities very seriously. So when Tony Stratton, until recently High Sherriff of Oxfordshire, asked if we’d like to join other top Oxfordshire companies to take a stronger, more sustainable approach to working with local charities in the community, we signed up straight away….

Continue reading

Oxford PharmaTrotters run (more than) a marathon for Sport Relief

Yesterday, Oxford PharmaGenesis really went the extra mile to raise money for Sport Relief. Our keen trotters ran a total of 32.5 miles over courses in Tubney, Oxfordshire, Trafalgar Square, London, and Newtown, PA, USA, and raised more than £300.

Continue reading